Lack of a Clinically Meaningful Drug Interaction Between the HIV‐1 Antiretroviral Agents Islatravir, Dolutegravir, and Tenofovir Disoproxil Fumarate

Islatravir, an investigational nucleoside reverse transcriptase translocation inhibitor, is in clinical development for the treatment and prevention of HIV‐1 infection. Because islatravir may be coadministered with other antiretroviral agents, assessment of potential drug‐drug interactions are warra...

Descripción completa

Detalles Bibliográficos
Autores principales: Rudd, Deanne Jackson, Zhang, Saijuan, Fillgrove, Kerry L., Fox‐Bosetti, Sabrina, Matthews, Randolph P., Friedman, Evan, Armas, Danielle, Stoch, S. Aubrey, Iwamoto, Marian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298070/
https://www.ncbi.nlm.nih.gov/pubmed/34676683
http://dx.doi.org/10.1002/cpdd.1026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298070/
https://www.ncbi.nlm.nih.gov/pubmed/34676683
http://dx.doi.org/10.1002/cpdd.1026

Ejemplares similares